Valuation: Transcat, Inc.

Capitalization 734M 707M 664M 590M 1.05B 64.29B 1.17B 8B 2.97B 26.34B 2.75B 2.7B 111B P/E ratio 2025 *
53.9x
P/E ratio 2026 * 49.8x
Enterprise value 734M 707M 664M 590M 1.05B 64.29B 1.17B 8B 2.97B 26.34B 2.75B 2.7B 111B EV / Sales 2025 *
2.64x
EV / Sales 2026 * 2.43x
Free-Float
96.4%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.14%
1 week+1.77%
Current month+1.36%
1 month-25.83%
3 months-27.04%
6 months-29.27%
Current year-26.17%
More quotes
1 week
74.14
Extreme 74.14
82.40
1 month
73.37
Extreme 73.37
107.46
Current year
73.37
Extreme 73.37
111.29
1 year
73.37
Extreme 73.37
147.12
3 years
50.32
Extreme 50.32
147.12
5 years
16.50
Extreme 16.5
147.12
10 years
8.26
Extreme 8.26
147.12
More quotes
Director TitleAgeSince
Chief Executive Officer 61 08/07/2013
Director of Finance/CFO 56 31/07/2022
Chief Operating Officer 54 07/04/2024
Manager TitleAgeSince
Chairman 75 08/07/2013
Director/Board Member 61 08/09/2015
Chairman 63 08/09/2020
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-1.14%+1.77%-27.89%+8.93%734M
+0.71%-9.13%-7.46%+4.68%99.34B
-0.08%+6.26%+7.21%-1.37%31.2B
-0.99%-1.77%+17.42%+20.81%24.02B
-2.61%-4.26%+55.83%-24.17%20.02B
+1.70%+4.10%+81.24%+157.22%16.54B
+1.56%+1.66%-22.41%-3.14%15.11B
-1.50%-5.67%+33.21%+19.87%13.9B
+3.24%-7.08%+101.53%+41.74%8.97B
+10.00%+15.45%+55.54%-8.56%8.69B
Average +1.08%+1.15%+29.42%+21.60% 23.85B
Weighted average by Cap. +0.57%-2.96%+16.18%+14.99%
See all sector performances

Financials

2025 *2026 *
Net sales 278M 268M 251M 223M 397M 24.32B 442M 3.03B 1.12B 9.96B 1.04B 1.02B 42.17B 303M 292M 274M 243M 433M 26.5B 481M 3.3B 1.22B 10.86B 1.13B 1.11B 45.95B
Net income 13.59M 13.09M 12.29M 10.92M 19.44M 1.19B 21.62M 148M 54.88M 487M 50.9M 49.9M 2.06B 15.31M 14.75M 13.85M 12.3M 21.9M 1.34B 24.36M 167M 61.83M 549M 57.35M 56.22M 2.32B
Net Debt - -
More financial data * Estimated data
Logo Transcat, Inc.
Transcat, Inc. is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, computerized maintenance management system (CMMS), and pipette services. It is focused on providing services and products to regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Its segments include Service and Distribution. Its Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. Its Distribution segment sells and rents national and proprietary brand instruments to customers globally. It provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 26 calibration service centers located across the United States, Puerto Rico, Canada, and Ireland.
Employees
1,104
More about the company
Date Price Change Volume
06/02/25 78.07 $ -0.99% 27,650
05/02/25 78.85 $ -0.57% 87,561
04/02/25 79.30 $ +2.69% 113,718
03/02/25 77.22 $ +0.26% 108,401
31/01/25 77.02 $ +0.40% 134,494

Delayed Quote Nasdaq, February 06, 2025 at 07:36 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
78.85USD
Average target price
106.00USD
Spread / Average Target
+34.43%
Consensus

Quarterly revenue - Rate of surprise